Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 611-615

  Simard, Edgar P ^a   Naishadham, Deepa ^a   Saslow, Debbie ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

Cervical cancer; Disparity; Human papillomavirus (HPV); Incidence; Race

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GROUPS BY AGE; HEALTH DISPARITY; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TREND STUDY; UNITED STATES; UTERINE CERVIX CANCER;

EID: 84868584423     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.021     Document Type: Article

References (34)

1. G.K. Singh, B.A. Miller, B.F. Hankey, and B.K. Edwards Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000 Cancer 101 2004 1051 1057
2. S.S. Wang, M.E. Sherman, A. Hildesheim, J.V. Lacey Jr., and S. Devesa Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000 Cancer 100 2004 1035 1044
3. J.A. McDougall, M.M. Madeleine, J.R. Daling, and C.I. Li Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003 Cancer Causes Control 18 2007 1175 1186
4. Health, United States, 2010: With special feature on death and dying. In. Hyattsville, MD: National Center for Health Statistics; 2011.
5. V.A. Moyer Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement Ann. Intern. Med. 156 2012 880 891
6. D. Saslow, D. Solomon, H.W. Lawson, M. Killackey, S.L. Kulasingam, and J. Cain American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer CA Cancer J. Clin. 62 2012 147 172
7. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2011 Sub, Vintage 2009 Pops (1973-2009) < Katrina/Rita Population Adjustment > - Linked To County Attributes-Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission.
8. B.A. Kohler, E. Ward, B.J. McCarthy, M.J. Schymura, L.A. Ries, and C. Eheman Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system J. Natl. Cancer Inst. 103 2011 714 736
9. World Health Organization International Classification of Diseases for Oncology 3rd ed. 2000 World Health Organization Geneva, Switzerland
10. Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 7.0.5. In; 2012.
11. H.J. Kim, M.P. Fay, E.J. Feuer, and D.N. Midthune Permutation tests for joinpoint regression with applications to cancer rates Stat. Med. 19 2000 335 351
12. S.S. Devesa, J. Donaldson, and T. Fears Graphical presentation of trends in rates Am. J. Epidemiol. 141 1995 300 304
13. J. Rothman, S. Greenland, and T. Lash Modern epidemiology 2008 Lippincott Williams and Wilkins Philadelphia, PA
14. National Cancer Institute SEER summary staging manual - 2000: codes and coding instructions 2001 National Cancer Institute Bethesda, MD
15. G. Singh, B. Miller, B. Hankey, and B. Edwards Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999 2003 National Cancer Institute Bethesda, MD
16. E.K. Adams, N. Breen, and P.J. Joski Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000 Cancer 109 2007 348 358
17. H. Freeman, and B. Wingrove Excess cervical cancer mortality: a marker for low access to health care in poor communities 2005 National Cancer Institute, Center to Reduce Cancer Health Disparities Rockville, MD
18. A.Y. Akers, S.J. Newmann, and J.S. Smith Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States Curr. Probl. Cancer 31 2007 157 181
19. V.B. Benard, H.W. Lawson, C.R. Eheman, C. Anderson, and W. Helsel Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women Obstet. Gynecol. 105 2005 1323 1328
20. K. Khan, C.R. Curtis, D.U. Ekwueme, S. Stokley, C. Walker, and K. Roland Preventing cervical cancer: overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs Cancer 113 2008 3004 3012
21. V.B. Benard, W. Howe, J. Royalty, W. Helsel, W. Kammerer, and L.C. Richardson Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program J Womens Health (Larchmt) 2012
22. A.L. Coker, K.S. Eggleston, T.E. Meyer, K. Luchok, and I.P. Das What predicts adherence to follow-up recommendations for abnormal Pap tests among older women? Gynecol. Oncol. 105 2007 74 80
23. T.A. Battaglia, M.C. Santana, S. Bak, M. Gokhale, T.L. Lash, and A.S. Ash Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers Cancer 116 2010 913 921
24. I.C. Scarinci, F.A. Garcia, E. Kobetz, E.E. Partridge, H.M. Brandt, and M.C. Bell Cervical cancer prevention: new tools and old barriers Cancer 116 2010 2531 2542
25. S.E. Brooks Cervical cancer screening and the older woman: obstacles and opportunities Cancer Pract. 4 1996 125 129
26. A.E. Rader, P.G. Rose, M. Rodriguez, S. Mansbacher, D. Pitlik, and F.W. Abdul-Karim Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management Acta Cytol. 43 1999 357 362
27. J.T. Keating, and H.H. Wang Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women Cancer 93 2001 100 105
28. T.C. Wright Jr., L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, and D. Solomon 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests Am. J. Obstet. Gynecol. 197 2007 346 355
29. T. Zheng, T.R. Holford, Z. Ma, Y. Chen, W. Liu, and B.A. Ward The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon Int. J. Epidemiol. 25 1996 252 258
30. D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'Connor, and M. Prey The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
31. M.K. Whiteman, S.D. Hillis, D.J. Jamieson, B. Morrow, M.N. Podgornik, and K.M. Brett Inpatient hysterectomy surveillance in the United States, 2000-2004 Am. J. Obstet. Gynecol. 198 34 2008 e1 7
32. R.C. Dicker, M.J. Scally, J.R. Greenspan, P.M. Layde, H.W. Ory, and J.M. Maze Hysterectomy among women of reproductive age. Trends in the United States, 1970-1978 JAMA 248 1982 323 327
33. J.K. Bower, P.J. Schreiner, B. Sternfeld, and C.E. Lewis Black-White differences in hysterectomy prevalence: the CARDIA study Am. J. Public Health 99 2009 300 307
34. L.S. Wilcox, L.M. Koonin, R. Pokras, L.T. Strauss, Z. Xia, and H.B. Peterson Hysterectomy in the United States, 1988-1990 Obstet. Gynecol. 83 1994 549 555